Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis.
van Manen MJG, Birring SS, Vancheri C, Vindigni V, Renzoni E, Russell AM, Wapenaar M, Cottin V, Wijsenbeek MS. van Manen MJG, et al. Among authors: wapenaar m. Eur Respir J. 2017 Oct 19;50(4):1701157. doi: 10.1183/13993003.01157-2017. Print 2017 Oct. Eur Respir J. 2017. PMID: 29051272 Free PMC article.
Daily home spirometry to detect early steroid treatment effects in newly treated pulmonary sarcoidosis.
Broos CE, Wapenaar M, Looman CWN, In 't Veen JCCM, van den Toorn LM, Overbeek MJ, Grootenboers MJJH, Heller R, Mostard RL, Poell LHC, Hoogsteden HC, Kool M, Wijsenbeek MS, van den Blink B. Broos CE, et al. Among authors: wapenaar m. Eur Respir J. 2018 Jan 18;51(1):1702089. doi: 10.1183/13993003.02089-2017. Print 2018 Jan. Eur Respir J. 2018. PMID: 29348185 Free article. No abstract available.
The effect of the walk-bike on quality of life and exercise capacity in patients with idiopathic pulmonary fibrosis: a feasibility study.
Wapenaar M, Bendstrup E, Molina-Molina M, Stessel MKN, Huremovic J, Bakker EW, Kardys I, Aerts JGJV, Wijsenbeek MS. Wapenaar M, et al. Sarcoidosis Vasc Diffuse Lung Dis. 2020;37(2):192-202. doi: 10.36141/svdld.v37i2.9433. Epub 2020 Jun 30. Sarcoidosis Vasc Diffuse Lung Dis. 2020. PMID: 33093783 Free PMC article. Clinical Trial.
The longitudinal use of EmPHasis-10 and CAMPHOR questionnaire health-related quality of life scores in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
Hendriks PM, van Thor MCJ, Wapenaar M, Chandoesing P, van den Toorn LM, van den Bosch AE, Post MC, Boomars KA. Hendriks PM, et al. Among authors: wapenaar m. Respir Med. 2021 Sep;186:106525. doi: 10.1016/j.rmed.2021.106525. Epub 2021 Jun 29. Respir Med. 2021. PMID: 34218166 Free article.
The Effects of a 10-wk Outpatient Pulmonary Rehabilitation Program on Exercise Performance, Muscle Strength, Soluble Biomarkers, and Quality of Life in Patients With Pulmonary Hypertension.
Koudstaal T, Wapenaar M, van Ranst D, Beesems R, van den Toorn L, van den Bosch A, Chandoesing P, Boomars K. Koudstaal T, et al. Among authors: wapenaar m. J Cardiopulm Rehabil Prev. 2019 Nov;39(6):397-402. doi: 10.1097/HCR.0000000000000443. J Cardiopulm Rehabil Prev. 2019. PMID: 31592929
Validation of the King's Sarcoidosis Questionnaire (KSQ) in a Dutch sarcoidosis population.
Van Manen MJ, Wapenaar M, Strookappe B, Drent M, Elfferich M, de Vries J, Gosker HR, Birring SS, Patel AS, van den Toorn L, van den Blink B, Boomars K, Hoitsma E, Wijsenbeek MS. Van Manen MJ, et al. Among authors: wapenaar m. Sarcoidosis Vasc Diffuse Lung Dis. 2016 Mar 29;33(1):75-82. Sarcoidosis Vasc Diffuse Lung Dis. 2016. PMID: 27055839
63 results